Twenty years ago, James Chen stood before the World Bank, convinced he had cracked a problem affecting 2.2 billion people. He had poured money into adjustable-power lenses, believing they would transform vision care in low-income countries. The World Bank said no. After two years of intense lobbying, the rejection was crushing. Most philanthropists would have walked away. Chen treated it as a starting point. He absorbed the failure and launched Vision for a Nation, a charity designed to test whether universal eyecare could work at a national scale. Experts insisted Rwanda, a country with limited infrastructure, could not support such a program. Chen took on the full financial risk himself. He trained 2,700 local nurses, conducted screenings across all 15,000 villages, and built a national health model that silenced the skeptics. Rwanda became the first country in the world to offer universal access to affordable vision correction. This journey taught Chen a crucial lesson: philanthropy should be judged not by intention but by outcome. In an era of fraying public trust, the scrutiny is sharper than ever. The debate is no longer about whether the rich are giving back, but what their giving achieves. Too many donors opt for safe, low-risk projects — eponymous hospital wings or alma mater donations — that offer quiet recognition but little real change. Chen believes this undermines the true superpower of philanthropy: its unique ability to serve as early-stage risk capital for radical, systemic innovation. Unlike governments or private institutions, philanthropists have no shareholders or taxpayers to please. They do not need permission to pursue ambitious goals. With that freedom comes the ability to absorb the costs of failure, and when a bold bet pays off, the benefits can be global. Chen's own work exemplifies this moonshot mindset. It took ten years to take Rwanda from concept to completion. Replicating that country by country with finite private capital would have taken lifetimes. To de-risk the issue for global institutions that still saw vision as a low priority, he founded the Clearly campaign. Rigorous research trials were commissioned to prove the economic impact of vision correction. A randomized controlled trial among tea-pickers in Assam, India, revealed that workers given glasses saw a 21.7% increase in daily productivity. By reframing eyecare from an overlooked health issue into a massive economic growth driver, Chen created the irrefutable evidence base that led the United Nations to pass its landmark 2021 resolution. All 193 member states committed to eyecare for all by 2030. This is what high-risk, bold philanthropy looks like in practice: using patient capital to prove a concept, absorb failure, and unlock institutional scale. Now, Chen argues, we stand on the precipice of a new era. The great wealth transfer will hand upward of $124 trillion to a new generation by 2048. Pioneering tech founders and AI investors are generating unprecedented wealth through radical disruption. They already possess the entrepreneurial drive and risk tolerance that modern philanthropy desperately lacks. Many may not yet know where to deploy their capital for maximum societal impact, but Chen insists we must not let this moment slip away. He encourages this new generation to bring their disruptive instincts into the philanthropic sphere, shaping their giving into a catalytic, high-reward force. Private capital has a singular, untapped power to confront the most daunting global crises. It is time it was deployed with the ambition it deserves.